Advertisement
U.S. markets close in 3 hours 50 minutes

West Pharmaceutical Services, Inc. (WST)

NYSE - Nasdaq Real Time Price. Currency in USD
361.92-1.37 (-0.38%)
As of 12:09PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close363.29
Open362.38
Bid361.69 x 900
Ask362.84 x 800
Day's Range358.47 - 363.84
52 Week Range309.43 - 415.73
Volume124,152
Avg. Volume525,060
Market Cap26.528B
Beta (5Y Monthly)1.05
PE Ratio (TTM)45.93
EPS (TTM)7.88
Earnings DateApr 25, 2024 - Apr 29, 2024
Forward Dividend & Yield0.80 (0.22%)
Ex-Dividend DateApr 23, 2024
1y Target Est400.43
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-31% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for WST

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • West Pharmaceutical Services, I
    WST: Lowering target price to $368.00WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $368.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • GuruFocus.com

    Decoding West Pharmaceutical Services Inc (WST): A Strategic SWOT Insight

    Insightful Analysis of West Pharmaceutical Services Inc's Market Position and Future Prospects

  • PR Newswire

    West Announces Second-Quarter 2024 Dividend

    West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2024 dividend of $0.20 per share. The dividend will be paid on May 1, 2024, to shareholders of record as of April 24, 2024.

  • Insider Monkey

    West Pharmaceutical Services (WST) Fell on Reduced Full Year Guidance

    Conestoga Capital Advisors, an asset management company, released its “SMid Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy outperformed the Russell 2500 Growth Index in the fourth quarter with a total return of 13.26% net-of-fess versus the benchmark return of 12.59%. The market had significant volatility throughout the […]